Former FDA chief Gottlieb joins Pfizer board

Former US Food and Drug Administration commissioner Scott Gottlieb, who returned to the private sector in April, has joined the board of Pfizer. Gottlieb received largely favorable reviews for his 2-year stint as FDA chief but is being criticized harshly for this latest role. Last week, Sen. Elizabeth Warren called on him to resign from Pfizer’s board, noting in a letter to Gottlieb that the role “is exactly the kind of ‘revolving door influence-peddling’ that causes Americans to lose faith in government.” A number of former FDA commissioners similarly have gone on to advise or serve on the boards of drug companies.